National Blood Foundation Scientific Research Grants Program
Submit the application by 11:59pm ET December 31, 2014. Application fee of $150 must accompany the application unless the primary investigator is an AABB individual member. The National Blood Foundation annually awards grants for one or two-year research projects, with a maximum award per grant of $75,000. NBF is pleased to announce the availability of funding in 2015 for scientific research projects related to transfusion medicine and cellular therapies. NBF will award grants for investigator-initiated original research in all aspects of blood banking, transfusion medicine, cellular therapies and patient ...
Source: ScanGrants feed - August 25, 2014 Category: Research Authors: National Blood Foundation Source Type: funding
Call for Applications: Research Seed Money Grant for APS Type 1 (Autoimmune Polyglandular Syndrome Type 1)
National Organization for Rare Disorders (NORD), with APS Type 1.org, Announces Research Seed Money Grant (up to $100,000) for APS Type 1 (Autoimmune Polyglandular Syndrome Type 1) Abstract Submission Deadline: July 10, 2014 NORD, with funding raised in coordination with the patient organization, , is accepting applications for a two-year grant, for a total of $100,000, to conduct a scientific and/or clinical research study related to APS Type 1. Also known as autoimmune polyglandular syndrome, type 1, APS Type 1 is a very rare hereditary disorder that strikes children and adults younger than 35 years of...
Source: ScanGrants feed - June 24, 2014 Category: Research Authors: National Organization for Rare Disorders/APS Type 1.Org Source Type: funding
2014 ASPIRE Rheumatology and Dermatology Research Awards
As competition for research funding increases, the ASPIRE program underscores Pfizer's commitment to supporting research in autoimmune diseases within rheumatology and dermatology. Mission The mission of the 2014 ASPIRE program is to support basic science, translational and clinical research through a competitive grants program that advances medical knowledge in the epidemiology, pathogenesis and treatment of selected diseases. The ASPIRE Program demonstrates Pfizer’s commitment to supporting promising investigators with an interest in advancing knowledge in defined disease areas within rheumatol...
Source: ScanGrants feed - June 17, 2014 Category: Research Authors: Pfizer Source Type: funding
FY14 National Health Education Program on Lupus for Healthcare Providers
Funding Opportunity Number: MP-CPI-14-001 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.137Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-OPHSClosing Date: Jun 09, 2014Award Ceiling: $2,000,000Expected Number of Awards: 1Creation Date: Apr 16, 2014Funding Opportunity Description: The purpose of the NHEPLHP is to eliminate lupus related health disparities among racial and ethnic minority populations disproportionately affected by this...
Source: Grants.gov - April 17, 2014 Category: Research Tags: Health Source Type: funding
NIAID Division of Allergy, Immunology and Transplantation: Statistical and Clinical Coordinating Center (UM2)
Funding Opportunity Number: RFA-AI-14-016 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c...
Source: Grants.gov - March 27, 2014 Category: Research Tags: Health Source Type: funding
NIAID Division of Allergy, Immunology and Transplantation: Statistical and Clinical Coordinating Center (UM2)
Funding Opportunity RFA-AI-14-016 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the Statistical and Clinical Coordinating Center, NIAID Division of Allergy, Immunology and Transplantation. The awardee will provide a broad range of support critical for the design, development, implementation, monitoring and analysis of clinical research carried out by multiple Division-supported programs in three disease areas: asthma and allergic diseases, autoimmune diseases, and transplantation. The scope of support to be provided includes statistical design and analysis, prot...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 26, 2014 Category: Research Source Type: funding
Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Research Sites (UH2/UH3)
Funding Opportunity Number: RFA-AR-14-016 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.84693.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a...
Source: Grants.gov - March 21, 2014 Category: Research Tags: Health Source Type: funding
Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Leadership Center (UM2)
Funding Opportunity Number: RFA-AR-14-015 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.84693.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a...
Source: Grants.gov - March 21, 2014 Category: Research Tags: Health Source Type: funding
Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Leadership Center (UM2)
Funding Opportunity RFA-AR-14-015 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis (RA) and Lupus Network Leadership Center. The AMP RA and Lupus Network is designed to ascertain and define shared and disease-specific biological pathways in order to identify relevant drug targets for the treatment of autoimmune diseases. This program will involve an enhanced systems-level understanding of gene expression and signaling in target tissues from affected end organs and peripheral blood cells. (Source: NI...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 21, 2014 Category: Research Source Type: funding
Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Research Sites (UH2/UH3)
Funding Opportunity RFA-AR-14-016 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis (RA) and Lupus Network Research Sites. The AMP RA and Lupus Network is designed to ascertain and define shared and disease-specific biological pathways in order to identify relevant drug targets for the treatment of autoimmune diseases. This program will involve an enhanced systems-level understanding of gene expression and signaling in target tissues from affected end organs and peripheral blood cells. (Source: NIH F...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 21, 2014 Category: Research Source Type: funding
Call for Applications: Iacocca Family Foundation to Support Innovative and Promising Research Projects on Type 1 Diabetes
Grant Amounts and Number of Grants The Foundation is very focused in its’ grant-making by making a few research grants a year. Accordingly, the Foundation will consider grants ranging in amounts of $10,000 to $500,000. For calendar year 2014, the Iacocca Family Foundation will accept grant applications to support innovative and promising research projects that will lead to a cure for type 1 diabetes. The Foundation will accept novel projects which directly accelerate a cure for type 1 diabetes or inform the understanding of the disease by a related or complementary mechanism of action. ...
Source: ScanGrants feed - December 31, 2013 Category: Research Authors: Iacocca Family Foundation Source Type: funding
Call for Applications: 2014 Charles & Daneen Stiefel Scholar Award in Autoimmune &/or Connective Tissue Diseases
Call for Applications: 2014 Charles & Daneen Stiefel Scholar Award in Autoimmune &/or Connective Tissue Diseases New Award Available for 2014—Apply by December 13, 2013 The Dermatology Foundation is pleased to introduce a new three-year research award made possible by a generous contribution from Charles and Daneen Stiefel—the 2014 Charles & Daneen Stiefel Scholar Award in Autoimmune &/or Connective Tissue Diseases. This award is designed to support outstanding investigators committed to elucidate the basis, pathophysiology, clinical manifestations, and/or treatment of autoimmune and...
Source: ScanGrants feed - November 19, 2013 Category: Research Authors: Dermatology Foundation Source Type: funding
Request for Proposals: 2013 ASPIRE Awards in Adult Vaccine Research
Mission The mission of the 2013 ASPIRE Awards in Adult Vaccine Research is to advance medical knowledge to better understand the burden of pneumococcal disease in adults. The burden of pneumococcal disease in the general adult population has been extensively studied; however, it is not well-defined in special populations, including subgroups with underlying disease comorbidities and/or those living in long-term community settings. Pfizer invites investigators to apply for the 2013 ASPIRE Awards in Adult Vaccine Research through submission of innovative research proposals for evaluation of the epidemiology ...
Source: ScanGrants feed - May 1, 2013 Category: Research Authors: Pfizer Source Type: funding
Call for Travel Fellowship Applications: Progressive Multifocal Leukoencephalopathy
June 19 - 20, 2013 The New York Academy of Sciences Presented by the Progressive Multifocal Leukoencephalopathy Consortium and The New York Academy of Sciences Progressive Multifocal Leukoencephalopathy (PML) is, in the general population, a rare but serious demyelinating disease of the brain, often resulting in severe disability or death and is caused by infection of oligodendrocytes by the JC polyomavirus (JCV). It is believed that fifty to sixty percent of the population is sero-positive for JCV, indicating exposure to the virus. Despite the high prevalence of JCV infection in the human population, which ty...
Source: ScanGrants feed - February 6, 2013 Category: Research Authors: Progressive Multifocal Leukoencephalopathy Consortium/New York Academy of Sciences Source Type: funding
Autoimmunity Centers of Excellence, Basic Research Program (U19)
Funding Opportunity Number: RFA-AI-12-060 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c...
Source: Grants.gov - January 16, 2013 Category: Research Tags: Health Source Type: funding
